Viewing Study NCT01234766


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-01-04 @ 9:36 AM
Study NCT ID: NCT01234766
Status: COMPLETED
Last Update Posted: 2021-05-18
First Post: 2010-10-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
Sponsor: Dartmouth-Hitchcock Medical Center
Organization: